Related Experiment Video
Updated: Jan 17, 2026

Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections
Published on: February 2, 2024
A novel case of prosthetic joint infection due to Clostridioides difficile successfully suppressed with oral
Holly Jordan1,2, Rikki Graham3, Sanmarie Schlebusch3,4
1Department of Infectious Diseases, John Hunter Hospital, Newcastle, NSW, Australia.
Abstract:
Extra-colonic infections caused by Clostridioides difficile are exceptionally rare, with prosthetic joint infections (PJIs) comprising only a small fraction of the reported cases. Moreover, there is limited guidance on the optimal management of such infections. We present the case of a 76-year-old man who developed a left hip PJI due to C. difficile 6 weeks after undergoing surgical revision for a periprosthetic fracture. Given the complexity of the case, curative surgical intervention was not considered feasible. The patient was treated with repeated debridement, intravenous vancomycin and oral (PO) metronidazole, followed by successful suppression with PO doxycycline - a novel therapeutic approach not previously documented. To date, only seven cases of C. difficile-associated PJI have been reported in the literature; this is the first known instance in which suppression of a C. difficile PJI has been achieved and the first to utilize whole-genome sequencing for further analysis of the isolate.
Insights
Extra-colonic Clostridioides difficile infections are rare, especially prosthetic joint infections (PJIs). This case highlights successful suppression of a C. difficile PJI using a novel doxycycline regimen, offering new management strategies.
Area of Science:
- Infectious Diseases
- Orthopedic Surgery
- Microbiology
Background:
- Extra-colonic Clostridioides difficile infections are rare.
- Prosthetic joint infections (PJIs) are an uncommon manifestation of C. difficile.
- Limited guidance exists for managing C. difficile-associated PJIs.
Related Concept Videos
Endocarditis III: Medical Management
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Endocarditis IV: Nursing Management
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.

